Advantage Capital, a leading impact investment firm that invests with intention in underserved areas, in partnership with the Community Development Venture Capital Alliance, has announced a $5 million investment in Gravity Diagnostics. Based in Covington, Kentucky, Gravity Diagnostics is a clinical laboratory providing innovative testing solutions in toxicology, pharmacogenetics, infectious and upper respiratory diseases, blood diagnostics, and COVID-19 testing.

The financing will enable Gravity Diagnostics to enhance its state-of-the-art facility, expand its service offerings, and support new product development. The company also plans to hire additional employees across sales, marketing, and other functions, growing its workforce of more than 300 employees.

Read press release here.